Cellectar Biosciences GAAP EPS of -$0.57 misses by $0.05
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
600+ sources. One page. See who else covered it.
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Plus: Eli Lilly alleges black market weight loss drug sellers; shippers don’t buy Trump’s Hormuz strait claims
Revenue grows 5.3%, thanks to increased average fares and ridership on the company’s public transport services
Earnings per share come in at S$0.045, down from S$0.0467 a year earlier